Back
Immunome 10K Form
Sell
48
IMNM
Immunome
Last Price:
12.96
Seasonality Move:
24.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-25 | 10K | IMNM/Immunome Annual |
| 2020-11-16 | 10Q | IMNM/Immunome Quarterly |
Receive IMNM News And Ratings
See the #1 stock for the next 7 days that we like better than IMNM
IMNM Financial Statistics
Sales & Book Value
| Annual Sales: | $14.02M |
|---|---|
| Cash Flow: | $-52.46M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.23 |
| Price / Book: | 3.07 |
Profitability
| EPS (TTM): | -15.65170 |
|---|---|
| Net Income (TTM): | $-262.59M |
| Gross Margin: | -- |
| Return on Equity: | -194.6% |
| Return on Assets: | -146.03% |
Immunome Earnings Forecast
Key Immunome Financial Ratios
- The Research & Development expenses have been 164.71% of Revenue.
- The Interest Expense is -0.04% of Operating Income.
- Per Share Earnings over the last 6 years have been positive in 1 years.
Immunome Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMNM |
| Website: | immunome.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 7.12 |
| Quick Ratio: | 6.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |